Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

239
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
239
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

216
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
216
Tissue Transplantation01:24

Tissue Transplantation

794
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
794
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

220
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
220

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Understanding the Impact of Heart Allocation on Durable LVAD Use: Trust but Verify.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2026
Same author

Neutrophil-to-lymphocyte ratio in patients with low-flow aortic stenosis undergoing transcatheter aortic valve implantation.

Journal of cardiology·2026
Same author

Ambulatory Stage C2D Heart Failure Definitions and Current Therapeutic Approaches: JACC: Heart Failure Position Statement.

JACC. Heart failure·2026
Same author

Tricuspid Valve Academic Research Consortium-2 (TVARC-2): Trial Design and Endpoints

Journal of the American College of Cardiology·2026
Same author

Sex-Based Differences in Advanced Heart Failure.

Heart failure clinics·2026
Same author

Reperfusion therapy for older patients with acute myocardial infarction and cardiogenic shock.

Cardiovascular revascularization medicine : including molecular interventions·2026

Related Experiment Video

Updated: Dec 21, 2025

A Modified Method for Heterotopic Mouse Heart Transplantion
11:29

A Modified Method for Heterotopic Mouse Heart Transplantion

Published on: June 23, 2014

13.0K

Heart Retransplantation: Candidacy, Outcomes, and Management.

Maya H Barghash1,2, Sean P Pinney1,2

  • 11Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, USA.

Current Transplantation Reports
|May 22, 2020
PubMed
Summary

Heart retransplantation offers improved survival for carefully selected patients, particularly those with cardiac allograft vasculopathy (CAV) over a year post-transplant. Further research is needed for optimal timing and management strategies.

Keywords:
Advanced heart failureHeart transplantRetransplantation

More Related Videos

Murine Heterotopic Heart Transplant Technique
10:27

Murine Heterotopic Heart Transplant Technique

Published on: July 8, 2014

17.5K
Optimization of the Cuff Technique for Murine Heart Transplantation
14:01

Optimization of the Cuff Technique for Murine Heart Transplantation

Published on: June 26, 2020

9.9K

Related Experiment Videos

Last Updated: Dec 21, 2025

A Modified Method for Heterotopic Mouse Heart Transplantion
11:29

A Modified Method for Heterotopic Mouse Heart Transplantion

Published on: June 23, 2014

13.0K
Murine Heterotopic Heart Transplant Technique
10:27

Murine Heterotopic Heart Transplant Technique

Published on: July 8, 2014

17.5K
Optimization of the Cuff Technique for Murine Heart Transplantation
14:01

Optimization of the Cuff Technique for Murine Heart Transplantation

Published on: June 26, 2020

9.9K

Area of Science:

  • Cardiology
  • Transplantation Medicine
  • Immunology

Background:

  • Heart retransplantation is a complex procedure with debated outcomes.
  • Understanding its incidence, epidemiology, and risk factors is crucial for patient selection.

Purpose of the Study:

  • To determine the incidence and epidemiology of adult and pediatric heart retransplantation.
  • To identify risk factors for adverse outcomes after heart retransplantation.
  • To guide recipient selection for improved retransplantation success.

Main Methods:

  • Review of adult and pediatric heart retransplantation cases.
  • Analysis of epidemiological data and survival rates.
  • Identification and evaluation of risk factors for adverse outcomes.

Main Results:

  • Heart retransplantation is associated with lower short- and long-term survival compared to primary heart transplantation.
  • Retransplantation is less controversial in pediatric populations.
  • Improved survival in recent eras for patients retransplanted for CAV, >1 year post-transplant, and not critically ill.

Conclusions:

  • Appropriate patient selection can lead to retransplantation survival rates approaching those of primary transplantation.
  • Cardiac Allograft Vasculopathy (CAV) is a key indication for retransplantation with better outcomes.
  • Further research is essential for optimizing retransplantation timing and post-transplant management.